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David S. Celermajer, MBBS, PHD, DSC,* Martin K. Ng, MBBS, PHD*A 30-year-old man with complex congenitalheart disease presented with severe heartfailure. He was born with a double-inletFIGURE 1 Complex Congenital Heart Disease Imaging
(A) The aorto-pulmonary window allows the pulmonary valve to be the
arteries. The restrictive bulboventricular foramen prevents the aortic va
struction of an aortogram showing the steep-angled aortic arch. When a
A 1-mm short tip super stiff wire was used to overcome the situation.
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FIGURE 2 Valve-in-Valve Replacement Into the Pulmonary Position Through
the Ascending Aorta
Contrast injection showed the patency of the aorto-pulmonary window and the lack
of valve regurgitation (Online Video 1).
FIGURE 3 CT Scan Reconstruction 1 Month After the Replacement
The anatomical relationships of the newly implanted valve, the aorto-pulmonary window,
and the coronary arteries are shown (see also Online Video 2). CT ¼ computed
tomography.
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e1341999, by a Damus-Kaye-Stanzel procedure (anasto-
mosis of the pulmonary artery proximal remnant to
the ascending aorta for restrictive bulboventricular
foramen) with pulmonary valve replacement using
a 21-mm stentless bioprosthetic valve (Figure 1A).
Fourteen years later, he presented with severe bio-
prosthetic valve stenosis (mean gradient 41 mm Hg
in the setting of severe systolic dysfunction). He
also had long-standing protein-losing enteropathy.
As he was deemed too high risk for surgical valve
re-replacement, transcatheter implantation into the
outlet ventriculo-arterial (pulmonary) valve position
was proposed.
Due to the small size of the previous bio-
prosthesis (internal diameters 18.2 mm and 15.6
mm), a self-expanding supra-annular transcatheter
valve (23-mm CoreValve, Medtronic, Minneapolis,
Minnesota) was chosen to reduce the risk of high
post-procedural transvalvular gradient. The levo-
transposition of the great arteries anatomy dis-
torted the aortic arch angulation, making its passage
challenging (Figure 1B). The CoreValve device was
deployed under rapid pacing and post-deployment
balloon valvuloplasty (Cristal 20-mm balloon,
BALT, Montmorency, France) was performed to
optimize expansion (Figure 2, Online Video 1). The
patient recovered uneventfully after the procedure
and improved signiﬁcantly. One-month echocardi-
ography and computed tomography scan conﬁrmed
a normally functioning CoreValve (mean gradient
10 mm Hg) without aortic regurgitation (Figure 3,
Online Video 2).
Although transcatheter aortic valves have been
developed for treatment of high-risk senile calciﬁc
stenosis, there has been increasing interest in their
applications in different clinical scenarios (1).
Previous experiences of transcatheter valve-in-valve
replacement have shown its feasibility for treat-
ment of failing bioprosthesis predominantly in the
aortic position (2). Our case highlights the importance
of computed tomography imaging to optimize pro-
cedural planning in complex cardiovascular anato-
mies and how transcatheter valve technologies can be
adapted to treat valvular pathologies in congenital
heart disease.
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APPENDIX For accompanying videos,
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